Using Innovative Adaptive Design to Improve Outcomes in Drug & Medical Device Development
Adaptive clinical trials can dramatically improve clinical trial efficiency and productivity, and are rapidly gaining traction in our industry. They have strong regulatory and ethical backing, save significant amounts of money, improve critical decision-making and can reduce late phase attrition’.
OCTANe has teamed up with Aptiv Solutions to create to two cutting edge breakfast seminars on the use of innovative adaptive design in drug and medical device development. The seminars focuses on the latest developments in this field including feedback from an Executive Roundtable held at the Tufts Centre for the Study of Drug Development on ‘Leveraging Adaptive Trial Designs to Do Better Science and Reduce Development Cost and Time’.
Ken Getz - Senior Research Fellow and Director of Sponsored Programs, Tufts Centre for the Study of Drug Development
Vlad Dragalin - Senior Vice-President, Aptiv Solutions Innovation Center